Acutaas Chemicals share news, announcements and annual reports
NSE: ACUTAASBSE: 543349Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,710.00.
29 Oct: open ₹3,700.00, high ₹4,032.20, low ₹3,673.30
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹32,558 Cr347th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 74.14
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 17.53
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.06%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 26.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 29,36,87822.4% delivered
Acutaas Chemicals analyst meets
95 filed, newest first. Page 2 of 2.
Jun 2023
2 Jun · Analysts
1 Jun · Analysts
1 Jun · Analysts
May 2023
29 May · Analysts
20 May · Analysts
18 May · Analysts
17 May · Analysts
11 May · Analysts
Mar 2023
31 Mar · Analysts
29 Mar · Analysts
15 Mar · Analysts
7 Mar · Analysts
4 Mar · Analysts
Feb 2023
17 Feb · Analysts
9 Feb · Analysts
6 Feb · Analysts
Jan 2023
31 Jan · Analysts
Dec 2022
28 Dec · Analysts
19 Dec · Analysts
Nov 2022
Aug 2022
23 Aug · Analysts
16 Aug · Analysts
May 2022
13 May · Analysts
Feb 2022
18 Feb · Analysts
17 Feb · Analysts
12 Feb · Analysts
10 Feb · Analysts
4 Feb · Analysts
Jan 2022
1 Jan · Analysts
Dec 2021
31 Dec · Analysts
29 Dec · Analysts
28 Dec · Analysts
23 Dec · Analysts
21 Dec · Analysts
10 Dec · Analysts
2 Dec · Analysts
Oct 2021
28 Oct · Analysts
27 Oct · Analysts
21 Oct · Analysts
Sep 2021
28 Sep · Analysts